Apyx Medical (APYX) Non-Current Deffered Revenue (2014 - 2026)

Apyx Medical's Non-Current Deffered Revenue history runs 12 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Non-Current Deffered Revenue fell 5.28% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 5.28% YoY) and the FY2025 annual result came in at $1.0 million, down 6.08% from the prior year.
• Non-Current Deffered Revenue was $1.1 million for Q1 2026 at Apyx Medical, up from $1.0 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $1.4 million in Q4 2022 and bottomed at $1.0 million in Q4 2025.
• A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue surged 62.11% — and 2023, when it slipped 11.51%.
• Apyx Medical's Non-Current Deffered Revenue stood at $1.4 million in 2022, then dropped by 11.51% to $1.2 million in 2023, then decreased by 10.27% to $1.1 million in 2024, then dropped by 6.08% to $1.0 million in 2025, then rose by 7.71% to $1.1 million in 2026.
• Business Quant data shows APYX's Non-Current Deffered Revenue at $1.1 million in Q1 2026, $1.0 million in Q4 2025, and $1.2 million in Q3 2025.